The association of linear energy transfer and dose with radiation necrosis after pencil beam scanning proton therapy in pediatric posterior fossa tumors: Association of dose and LET with radiation necrosis

Abstract

Listen

Translate article

IntroductionProton therapy is the preferred treatment modality for most pediatric central nervous system (CNS) tumors. The risk of radiation necrosis may be increased at the distal end of the beam due to an increase in linear energy transfer (LET) and relative biological effective (RBE) dose. We report on the association of linear energy transfer (LET) and dose with radiation necrosis after pencil beam scanning proton therapy in pediatric posterior fossa tumors using a case-control framework. Materials and MethodsFrom 2019 to 2022, 33 patients less than or equal to 18 years of age treated with first line proton therapy for primary tumors in the posterior fossa and with 6 or more months of follow up MRI imaging were retrospectively identified. Nine patients with imaging changes consistent with necrosis were matched with controls in a 1:2 fashion based on age, sex, dose, and follow-up time from proton therapy. Dose [Gy (RBE)] and dose-averaged LET (LETd) values for target structures and organs at risk (OAR) were computed and compared between cases and controls. ResultsWithin the whole cohort, mean age was 6.6 years (SD=4.77) with a median follow up time of 24.1 months. Within the case-control matched cohort (18 controls, 9 cases), there were no significant differences in age, sex, time to follow up, tumor location, dose, and use of concurrent chemotherapy. Mean time to necrotic imaging finding was 4.47 months (SD=2.03). Cases demonstrated significantly higher brainstem D50 (p=0.02). LETd was not different between cases and controls. However, when using a combined metric of higher brainstem dose (> 47.5 [Gy (RBE)]) and higher LETd (>3.5 keV/µm), a greater proportion of cases compared to controls met this metric (89% vs. 39%, p=0.02). ConclusionsCombined effects of intermediate-to-high dose and LETd in the brainstem may contribute to greater necrosis risk after pencil beam scanning proton therapy in children with posterior fossa tumors.